Klinger Shannon Thyme, Chief Legal Officer at Moderna Inc. ($MRNA), made one open market sale of company shares in the last year, totaling about $726 thousand. Her most recent sale occurred on March 2, 2026. This activity ranks her 5,653rd among nearly 12,000 insiders in our database, well below the average of $8.6 million across about six sales per insider. She recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 11797 | $0.00 | 71,486.0000 | 389,000,000 | 19.76% | 0.00% |
| March 5, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 11797 | $0.00 | 129,774.0000 | 389,000,000 | 8.33% | 0.00% |
| March 5, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 5704 | $57.80 | 65,782.0000 | 389,000,000 | 7.98% | 0.00% |
| March 1, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Restricted Stock Units | 38553 | $0.00 | 38,553.0000 | 389,000,000 | 9999.99% | 0.01% |
| March 1, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Stock Option (Right to Buy) | 29275 | $0.00 | 29,275.0000 | 389,000,000 | 9999.99% | 0.01% |
| March 2, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Stock Option (Right to Buy) | 13885 | $0.00 | 41,658.0000 | 389,000,000 | 25.00% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 233 | $0.00 | 54,760.0000 | 389,000,000 | 0.43% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 113 | $51.71 | 54,647.0000 | 389,000,000 | 0.21% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 329 | $0.00 | 54,976.0000 | 389,000,000 | 0.60% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 160 | $51.71 | 54,816.0000 | 389,000,000 | 0.29% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 774 | $0.00 | 55,590.0000 | 389,000,000 | 1.41% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 375 | $51.71 | 55,215.0000 | 389,000,000 | 0.67% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 8663 | $0.00 | 63,878.0000 | 389,000,000 | 15.69% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 4189 | $51.71 | 59,689.0000 | 389,000,000 | 6.56% | 0.00% |
| March 2, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 13885 | $30.96 | 73,574.0000 | 389,000,000 | 23.26% | 0.00% |
| March 2, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 13885 | $52.29 | 59,689.0000 | 389,000,000 | 18.87% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 233 | $0.00 | 0.0000 | 389,000,000 | 100.00% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 329 | $0.00 | 1,315.0000 | 389,000,000 | 20.01% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 774 | $0.00 | 6,189.0000 | 389,000,000 | 11.12% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 8663 | $0.00 | 25,992.0000 | 389,000,000 | 25.00% | 0.00% |
| Feb. 11, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Common Stock | 2630 | $0.00 | 55,861.0000 | 389,000,000 | 4.94% | 0.00% |
| Feb. 11, 2026 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 1334 | $41.99 | 54,527.0000 | 389,000,000 | 2.39% | 0.00% |
| Dec. 5, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 22817 | $25.49 | 53,231.0000 | 390,000,000 | 30.00% | 0.01% |
| Dec. 5, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 47190 | $0.00 | 76,048.0000 | 390,000,000 | 163.52% | 0.01% |
| Dec. 5, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 47190 | $0.00 | 141,571.0000 | 390,000,000 | 25.00% | 0.01% |
| Dec. 1, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 233 | $0.00 | 28,971.0000 | 390,000,000 | 0.81% | 0.00% |
| Dec. 1, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 233 | $0.00 | 233.0000 | 390,000,000 | 50.00% | 0.00% |
| Dec. 1, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 113 | $25.98 | 28,858.0000 | 390,000,000 | 0.39% | 0.00% |
| Nov. 26, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 773 | $0.00 | 6,963.0000 | 390,000,000 | 9.99% | 0.00% |
| Nov. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 329 | $0.00 | 1,644.0000 | 390,000,000 | 16.68% | 0.00% |
| Nov. 26, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 773 | $0.00 | 28,943.0000 | 390,000,000 | 2.74% | 0.00% |
| Nov. 26, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 374 | $24.75 | 28,569.0000 | 390,000,000 | 1.29% | 0.00% |
| Nov. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 329 | $0.00 | 28,898.0000 | 390,000,000 | 1.15% | 0.00% |
| Nov. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 160 | $25.01 | 28,738.0000 | 390,000,000 | 0.55% | 0.00% |
| Aug. 29, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 232 | $0.00 | 466.0000 | 384,000,000 | 33.24% | 0.00% |
| Aug. 29, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 113 | $24.47 | 28,170.0000 | 384,000,000 | 0.40% | 0.00% |
| Aug. 29, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 232 | $0.00 | 28,283.0000 | 384,000,000 | 0.83% | 0.00% |
| Aug. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 375 | $24.73 | 27,882.0000 | 384,000,000 | 1.33% | 0.00% |
| Aug. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 160 | $25.10 | 28,051.0000 | 384,000,000 | 0.57% | 0.00% |
| Aug. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 774 | $0.00 | 7,736.0000 | 384,000,000 | 9.10% | 0.00% |
| Aug. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 329 | $0.00 | 1,973.0000 | 384,000,000 | 14.29% | 0.00% |
| Aug. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 774 | $0.00 | 28,257.0000 | 384,000,000 | 2.82% | 0.00% |
| Aug. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 329 | $0.00 | 28,211.0000 | 384,000,000 | 1.18% | 0.00% |
| June 6, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1139 | $0.00 | 28,034.0000 | 384,000,000 | 4.23% | 0.00% |
| June 6, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 551 | $26.12 | 27,483.0000 | 384,000,000 | 1.97% | 0.00% |
| June 6, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1139 | $0.00 | 0.0000 | 384,000,000 | 100.00% | 0.00% |
| May 30, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 233 | $0.00 | 698.0000 | 384,000,000 | 25.03% | 0.00% |
| May 30, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 113 | $26.93 | 26,300.0000 | 384,000,000 | 0.43% | 0.00% |
| May 30, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 233 | $0.00 | 26,413.0000 | 384,000,000 | 0.89% | 0.00% |
| May 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 328 | $0.00 | 26,339.0000 | 384,000,000 | 1.26% | 0.00% |
| May 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 159 | $26.76 | 26,180.0000 | 384,000,000 | 0.60% | 0.00% |
| May 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 773 | $0.00 | 8,510.0000 | 384,000,000 | 8.33% | 0.00% |
| May 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 328 | $0.00 | 2,302.0000 | 384,000,000 | 12.47% | 0.00% |
| May 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 374 | $26.26 | 26,011.0000 | 384,000,000 | 1.42% | 0.00% |
| May 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 773 | $0.00 | 26,385.0000 | 384,000,000 | 3.02% | 0.00% |
| March 7, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1139 | $0.00 | 1,139.0000 | 384,000,000 | 50.00% | 0.00% |
| March 7, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1139 | $0.00 | 26,163.0000 | 384,000,000 | 4.55% | 0.00% |
| March 7, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 551 | $34.30 | 25,612.0000 | 384,000,000 | 2.11% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 160 | $31.09 | 25,024.0000 | 384,000,000 | 0.64% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 233 | $0.00 | 24,968.0000 | 384,000,000 | 0.94% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 113 | $31.09 | 24,855.0000 | 384,000,000 | 0.45% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 329 | $0.00 | 25,184.0000 | 384,000,000 | 1.32% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 233 | $0.00 | 931.0000 | 384,000,000 | 20.02% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 329 | $0.00 | 2,630.0000 | 384,000,000 | 11.12% | 0.00% |
| March 1, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Stock Option (Right to Buy) | 55543 | $0.00 | 55,543.0000 | 384,000,000 | 9999.99% | 0.01% |
| March 1, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Restricted Stock Units | 34655 | $0.00 | 34,655.0000 | 384,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 3094 | $0.00 | 9,283.0000 | 384,000,000 | 25.00% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 1283 | $33.58 | 24,735.0000 | 384,000,000 | 4.93% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 2653 | $0.00 | 0.0000 | 384,000,000 | 100.00% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 3094 | $0.00 | 24,861.0000 | 384,000,000 | 14.21% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 1496 | $33.58 | 23,365.0000 | 384,000,000 | 6.02% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 2653 | $0.00 | 26,018.0000 | 384,000,000 | 11.35% | 0.00% |
| Feb. 12, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Common Stock | 2047 | $0.00 | 22,493.0000 | 384,000,000 | 10.01% | 0.00% |
| Feb. 12, 2025 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | F | Common Stock | 1068 | $30.93 | 21,425.0000 | 384,000,000 | 4.75% | 0.00% |
| Dec. 6, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1138 | $0.00 | 20,975.0000 | 399,000,000 | 5.74% | 0.00% |
| Dec. 6, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1138 | $0.00 | 2,278.0000 | 399,000,000 | 33.31% | 0.00% |
| Dec. 9, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 529 | $44.68 | 20,446.0000 | 399,000,000 | 2.52% | 0.00% |
| Dec. 5, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Restricted Stock Units | 188761 | $0.00 | 188,761.0000 | 399,000,000 | 9999.99% | 0.05% |
| Dec. 2, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 232 | $0.00 | 1,164.0000 | 399,000,000 | 16.62% | 0.00% |
| Dec. 2, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 232 | $0.00 | 19,949.0000 | 399,000,000 | 1.18% | 0.00% |
| Dec. 3, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 112 | $43.30 | 19,837.0000 | 399,000,000 | 0.56% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 329 | $0.00 | 18,483.0000 | 399,000,000 | 1.81% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 329 | $0.00 | 2,959.0000 | 399,000,000 | 10.01% | 0.00% |
| Nov. 29, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 1418 | $42.79 | 19,717.0000 | 399,000,000 | 6.71% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 2652 | $0.00 | 21,135.0000 | 399,000,000 | 14.35% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 2652 | $0.00 | 2,653.0000 | 399,000,000 | 49.99% | 0.00% |
| Sept. 6, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1139 | $0.00 | 18,705.0000 | 382,000,000 | 6.48% | 0.00% |
| Sept. 9, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 551 | $73.57 | 18,154.0000 | 382,000,000 | 2.95% | 0.00% |
| Sept. 6, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1139 | $0.00 | 3,416.0000 | 382,000,000 | 25.01% | 0.00% |
| Aug. 30, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 233 | $0.00 | 1,396.0000 | 382,000,000 | 14.30% | 0.00% |
| Aug. 30, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 233 | $0.00 | 17,680.0000 | 382,000,000 | 1.34% | 0.00% |
| Sept. 3, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 114 | $76.99 | 17,566.0000 | 382,000,000 | 0.64% | 0.00% |
| Aug. 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 329 | $0.00 | 3,288.0000 | 382,000,000 | 9.10% | 0.00% |
| Aug. 29, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 162 | $78.03 | 17,447.0000 | 382,000,000 | 0.92% | 0.00% |
| Aug. 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 329 | $0.00 | 17,609.0000 | 382,000,000 | 1.90% | 0.00% |
| Aug. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 2652 | $0.00 | 18,599.0000 | 382,000,000 | 16.63% | 0.00% |
| Aug. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 2652 | $0.00 | 5,305.0000 | 382,000,000 | 33.33% | 0.00% |
| Aug. 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 1319 | $79.39 | 17,280.0000 | 382,000,000 | 7.09% | 0.00% |
| June 7, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1139 | $0.00 | 4,555.0000 | 382,000,000 | 20.00% | 0.00% |
| June 7, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 9108 | $0.00 | 21,125.0000 | 382,000,000 | 75.79% | 0.00% |
| June 7, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1139 | $0.00 | 12,017.0000 | 382,000,000 | 10.47% | 0.00% |
| June 10, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 5178 | $148.09 | 15,947.0000 | 382,000,000 | 24.51% | 0.00% |
| June 7, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 9108 | $0.00 | 0.0000 | 382,000,000 | 100.00% | 0.00% |
| May 31, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 232 | $0.00 | 1,629.0000 | 382,000,000 | 12.47% | 0.00% |
| June 3, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 122 | $140.72 | 10,878.0000 | 382,000,000 | 1.11% | 0.00% |
| May 31, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 232 | $0.00 | 11,000.0000 | 382,000,000 | 2.15% | 0.00% |
| May 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 328 | $0.00 | 10,951.0000 | 382,000,000 | 3.09% | 0.00% |
| May 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 328 | $0.00 | 3,617.0000 | 382,000,000 | 8.31% | 0.00% |
| May 29, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 183 | $144.50 | 10,768.0000 | 382,000,000 | 1.67% | 0.00% |
| May 24, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 2652 | $0.00 | 11,919.0000 | 382,000,000 | 28.62% | 0.00% |
| May 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 1296 | $162.47 | 10,623.0000 | 382,000,000 | 10.87% | 0.00% |
| May 24, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 2652 | $0.00 | 7,957.0000 | 382,000,000 | 25.00% | 0.00% |
| March 8, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 544 | $99.05 | 9,267.0000 | 382,000,000 | 5.54% | 0.00% |
| March 7, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1138 | $0.00 | 9,811.0000 | 382,000,000 | 13.12% | 0.00% |
| March 7, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1138 | $0.00 | 5,694.0000 | 382,000,000 | 16.66% | 0.00% |
| March 1, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 233 | $0.00 | 1,861.0000 | 382,000,000 | 11.13% | 0.00% |
| March 1, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 233 | $0.00 | 8,790.0000 | 382,000,000 | 2.72% | 0.00% |
| March 4, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 117 | $94.34 | 8,673.0000 | 382,000,000 | 1.33% | 0.00% |
| Feb. 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1315 | $0.00 | 3,945.0000 | 382,000,000 | 25.00% | 0.00% |
| Feb. 28, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1315 | $0.00 | 9,227.0000 | 382,000,000 | 16.62% | 0.00% |
| Feb. 29, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 670 | $94.57 | 8,557.0000 | 382,000,000 | 7.26% | 0.00% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Stock Option (Right to Buy) | 60216 | $0.00 | 60,216.0000 | 382,000,000 | 9999.99% | 0.02% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Stock Option (Right to Buy) | 23635 | $0.00 | 23,635.0000 | 382,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Restricted Stock Units | 12377 | $0.00 | 12,377.0000 | 382,000,000 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Restricted Stock Units | 10609 | $0.00 | 10,609.0000 | 382,000,000 | 9999.99% | 0.00% |
| Dec. 8, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 563 | $79.09 | 7,912.0000 | 416,000,000 | 6.64% | 0.00% |
| Dec. 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1139 | $0.00 | 8,475.0000 | 416,000,000 | 15.53% | 0.00% |
| Dec. 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1139 | $0.00 | 6,832.0000 | 416,000,000 | 14.29% | 0.00% |
| Dec. 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 232 | $0.00 | 2,094.0000 | 416,000,000 | 9.97% | 0.00% |
| Dec. 4, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 111 | $79.31 | 7,336.0000 | 416,000,000 | 1.49% | 0.00% |
| Dec. 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 232 | $0.00 | 7,447.0000 | 416,000,000 | 3.22% | 0.00% |
| Sept. 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1138 | $0.00 | 7,772.0000 | 416,000,000 | 17.15% | 0.00% |
| Sept. 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1138 | $0.00 | 7,971.0000 | 416,000,000 | 12.49% | 0.00% |
| Sept. 8, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 557 | $107.22 | 7,215.0000 | 416,000,000 | 7.17% | 0.00% |
| Sept. 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 233 | $0.00 | 6,749.0000 | 416,000,000 | 3.58% | 0.00% |
| Sept. 5, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 115 | $111.44 | 6,634.0000 | 416,000,000 | 1.70% | 0.00% |
| Sept. 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 233 | $0.00 | 2,326.0000 | 416,000,000 | 9.11% | 0.00% |
| June 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1139 | $0.00 | 9,109.0000 | 416,000,000 | 11.11% | 0.00% |
| June 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1139 | $0.00 | 7,081.0000 | 416,000,000 | 19.17% | 0.00% |
| June 8, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 565 | $124.09 | 6,516.0000 | 416,000,000 | 7.98% | 0.00% |
| June 2, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 110 | $130.32 | 5,942.0000 | 416,000,000 | 1.82% | 0.00% |
| June 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 232 | $0.00 | 6,052.0000 | 416,000,000 | 3.99% | 0.00% |
| June 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 232 | $0.00 | 2,559.0000 | 416,000,000 | 8.31% | 0.00% |
| March 8, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 561 | $141.51 | 5,820.0000 | 416,000,000 | 8.79% | 0.00% |
| March 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 1138 | $0.00 | 6,381.0000 | 416,000,000 | 21.71% | 0.00% |
| March 7, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 1138 | $0.00 | 10,248.0000 | 416,000,000 | 9.99% | 0.00% |
| March 2, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | S | Common Stock | 459 | $136.43 | 5,243.0000 | 416,000,000 | 8.05% | 0.00% |
| March 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Restricted Stock Units | 930 | $0.00 | 2,791.0000 | 416,000,000 | 24.99% | 0.00% |
| March 1, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | M | Common Stock | 930 | $0.00 | 5,702.0000 | 416,000,000 | 19.49% | 0.00% |
| Feb. 28, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Restricted Stock Units | 5260 | $0.00 | 5,260.0000 | 416,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Moderna, Inc. | $MRNA | Klinger Shannon Thyme | Chief Legal Officer | A | Stock Option (Right to Buy) | 20040 | $0.00 | 20,040.0000 | 416,000,000 | 9999.99% | 0.00% |